Jefferies Downgrades Adeptus Health (ADPT) to Hold, Slashes PT to $13

November 2, 2016 7:17 AM EDT
Get Alerts ADPT Hot Sheet
Price: $8.37 +4.36%

Rating Summary:
    6 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade ADPT Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Jefferies downgraded Adeptus Health (NYSE: ADPT) from Buy to Hold with a price target of $13.00 (from $17.00).

Analyst Brian Tanquilut commented, "We are downgrading ADPT to Hold given our concerns about its balance sheet and cash flows. As A/R DSOs have risen from 54 days LY to 119 days at end-3Q16 and the company is now burning cash ($22MM in 3Q16 vs. cash generation of $11MM in 2Q15), ADPT is in a tight liquidity position and will have to raise more cash through debt/equity offerings in the next few months. Deteriorating SSS revs and EBITDA trends are also likely to keep pressure on ADPT shares NT."

The firm cut Q4 EPS from $0.83 to $0.22, FY 2016 EPS from $2.28 to $1.23 and FY 2017 EPS from $3.25 to $1.28.

For an analyst ratings summary and ratings history on Adeptus Health click here. For more ratings news on Adeptus Health click here.

Shares of Adeptus Health closed at $26.87 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change, Downgrades

Related Entities

Jefferies & Co

Add Your Comment